Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors

Molecular Medicine Reports

Volumn 10, Issue 4, 2014, Pages 1779-1785

  Shi, Qingqiang ^a   Li, Jing ^a   Feng, Ziqiang ^a   Zhao, Lvcui ^a   Luo, Lian ^a   You, Zhimei ^a   Li, Danyang ^a   Xia, Jing ^a   Zuo, Guowei ^a   Chen, Dilong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Activator protein 1; Ginsenoside Rh2; HepG2; Histone deacetylase; Matrix metalloproteinase 3

Indexed keywords

4-O-METHYL-12-O-TETRADECANOYLPHORBOL 13-ACETATE; GINSENOSIDE; GINSENOSIDE RH 2; HDAC4 PROTEIN, HUMAN; HISTONE DEACETYLASE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; REPRESSOR PROTEIN; STROMELYSIN; TRANSCRIPTION FACTOR AP 1;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL MOTION; DOWN REGULATION; DRUG EFFECTS; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER TUMOR; METABOLISM; PATHOLOGY;

CELL MOVEMENT; DOWN-REGULATION; GINSENOSIDES; HEP G2 CELLS; HISTONE DEACETYLASES; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 3; REPRESSOR PROTEINS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 84924220374     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2392     Document Type: Article

References (34)

1. Coradini D and Speranza A: Histone deacetylase inhibitors for treatment of hepatocellular carcinoma. Acta Pharmacol Sin 26: 1025-1033, 2005. (Pubitemid 41296939)
2. Quint K, Agaimy A, Di Fazio P, et al: Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC. Virchows Arch 459: 129-139, 2011.
3. Page AJ, Cosgrove DC, Philosophe B and Pawlik TM: Hepatocellular carcinoma: diagnosis, management, and prognosis. Surg Oncol Clin N Am 23: 289-311, 2014.
4. Zhu Q, Zhou L, Yang Z, et al: O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med Oncol 29: 985-993, 2012.
5. Ji Z, Wang T, Shao Z, et al: A population-based study examining hepatitis B virus infection and immunization rates in Northwest China. PLoS One 9: e97474, 2014.
6. Scaggiante B, Kazemi M, Pozzato G, et al: Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol 20: 1268-1288, 2014.
7. Chung KS, Cho SH, Shin JS, et al: Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression. Carcinogenesis 34: 331-340, 2013.
8. Christensen LP: Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 55: 1-99, 2009.
9. Tang XP, Tang GD, Fang CY, Liang ZH and Zhang LY: Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol 19: 1582-1592, 2013.
10. Wang Z, Zheng Q, Liu K, Li G and Zheng R: Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin Pharmacol Toxicol 98: 411-415, 2006.
11. Cheng CC, Yang SM, Huang CY, Chen JC, Chang WM and Hsu SL: Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol 55: 531-540, 2005.
12. Eferl R and Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003. (Pubitemid 37383716)
13. Mittelstadt ML and Patel RC: AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon β. PLoS One 7: e42152, 2012.
14. Wang L, Cheng X, Li H, et al: Quercetin reduces oxidative stress and inhibits activation of c-Jun N-terminal kinase/activator protein-1 signaling in an experimental mouse model of abdominal aortic aneurysm. Mol Med Rep 9: 435-442, 2014.
15. Eckert RL, Adhikary G, Young CA, et al: AP1 transcription factors in epidermal differentiation and skin cancer. J Skin Cancer 2013: 537028, 2013.
16. Barbetti V, Gozzini A, Cheloni G, et al: Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells. Epigenetics 8: 210-219, 2013.
17. Zhang M, Dai C, Zhu H, et al: Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9. Mol Cell Biochem 357: 387-395, 2011.
18. Zhang C, Li C, Zhu M, et al: Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. PLoS One 8: e62023, 2013.
19. Mendes O, Kim HT and Stoica G: Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis 22: 237-246, 2005. (Pubitemid 41298005)
20. Fanjul-Fernández M, Folgueras AR, Cabrera S and López-Otín C: Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 1803: 3-19, 2010.
21. Théret N, Musso O, Turlin B, et al: Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 34: 82-88, 2001. (Pubitemid 32591486)
22. Slattery ML, John E, Torres-Mejia G, et al: Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One 8: e63165, 2013.
23. Ishii Y, Nakasato Y, Kobayashi S, Yamazaki Y and Aoki T: A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma. J Exp Clin Cancer Res 22: 461-470, 2003. (Pubitemid 37205405)
24. Guo XX, Guo Q, Li Y, Lee SK, Wei XN and Jin YH: Ginsenoside rh2 induces human hepatoma cell apoptosisvia bax/bak triggered cytochrome C release and caspase-9/caspase-8 activation. Int J Mol Sci 13: 15523-15535, 2012.
25. Park HM, Kim SJ, Kim JS and Kang HS: Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways. Food Chem Toxicol 50: 2736-2741, 2012.
26. Naylor LH: Reporter gene technology: the future looks bright. Biochem Pharmacol 58: 749-757, 1999.
27. Brasier AR, Tate JE and Habener JF: Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7: 1116-1122, 1989. (Pubitemid 20022349)
28. Eckert RL, Adhikary G, Young CA, et al: AP1 transcription factors in epidermal differentiation and skin cancer. J Skin Cancer 2013: 537028, 2013.
29. Miotto B, Sagnier T, Berenger H, Bohmann D, Pradel J and Graba Y: Chameau HAT and DRpd3 HDAC function as antagonistic cofactors of JNK/AP-1-dependent transcription during Drosophila metamorphosis. Genes Dev 20: 101-112, 2006. (Pubitemid 43042671)
30. Correia AL, Mori H, Chen EI, Schmitt FC and Bissell MJ: The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β. Genes Dev 27: 805-817, 2013.
31. Choi MC, Cohen TJ, Barrientos T, et al: A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program. Mol Cell 47: 122-132, 2012.
32. Mendes O, Kim HT and Stoica G: Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis 22: 237-246, 2005. (Pubitemid 41298005)
33. Fanjul-Fernández M, Folgueras AR, Cabrera S and López-Otín C: Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 1803: 3-19, 2010.
34. Butticè G, Duterque-Coquillaud M, Basuyaux JP, Carrère S, Kurkinen M and Stéhelin D: Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13: 2297-2306, 1996.